摘要:
PROBLEM TO BE SOLVED: To provide a luminescent metal complex which is inexpensive and excellent in light emitting characteristics.SOLUTION: The luminescent metal complex for solving the problem contains a zinc salt and a ligand represented by formula (I) (In the formula, Sp is a C1-C4 alkylene group, E is selected from the group consisting of a methylene group, an ethylene group, O, Se, and NH, L is a heteroaryl group, and R is a C1-C4 hydrocarbon group).
摘要:
PROBLEM TO BE SOLVED: To provide a photosensitive resin composition that gives resin patterns with a large height difference when resin patterns having different heights are simultaneously formed on one substrate.SOLUTION: The photosensitive resin composition includes the following components (A), (B), (C) and (D): (A) a resin having a structural unit derived from at least one compound selected from the group consisting of an unsaturated carboxylic acid and an unsaturated carboxylic acid anhydride and a structural unit derived from a monomer having a 2-4C cyclic ether structure and an ethylenically unsaturated bond, in which the content of the structural unit derived from a monomer having a 2-4C cyclic ether structure and an ethylenically unsaturated bond is 30 to 99 mol% with respect to the whole structural units of the resin; (B) a polymerizable compound; (C) a polymerization initiator; and (D) a compound expressed by formula (1). In formula (1), Lrepresents a 1-6C alkane diyl group or -S-; Rand Reach represent a 1-6C alkyl group; and m and n each represent an integer of 0 to 3.
摘要:
PROBLEM TO BE SOLVED: To provide a dye-containing curable composition having a characteristic of high sensitivity, an excellent pattern formation property even after film-thinning with a high dye-concentration, no dye-elution, and high productivity; a color filter using this; and a manufacturing method thereof.SOLUTION: Provided are; a dye-containing curable composition containing an organic solvent-soluble dye (A), a curing agent (C) and a photosensitive compound (D), where the content of the organic solvent-soluble dye (A) is 45 mass% or more relative to all the solid components, the content of the curing agent (C) is 20 mass% or more and 55 mass% or less relative to all the solid components, and the photosensitive compound (D) is 2-(O-benzoyloxime)-1-[4-(phenylthio)phenyl]-1,2-octanedione as a photoinitiator; a color filter using this; and a manufacturing method thereof.
摘要:
PROBLEM TO BE SOLVED: To provide a manufacturing method for an aromatic sulfide compound with which the aromatic sulfide compound that is useful as a synthetic intermediate or various additives of dye, medicines, pesticide or the like can be manufactured in a high yield according to a method that is advantageous industrially.SOLUTION: An aromatic thiol compound is represented by a formula (1), wherein R, R. R. Rand Rare independent, respectively, may also be the same as or different from one another and indicate a hydrogen atom, a 1C-4C straight-chain or branched alkyl group, a cyano group, a nitro group, a hydroxy group, and a methoxy group or an ethoxy group. According to the manufacturing method, an aromatic sulfide compound is obtained by gas-phase reacting the aromatic thiol compound in the presence of active carbon.
摘要翻译:待解决的问题:提供一种芳族硫化物化合物的制造方法,可以以高产率制造可用作合成中间体的芳香族硫化合物或染料,药物,农药等的各种添加剂 根据在工业上有利的方法。 解决方案:芳族硫醇化合物由式(1)表示,其中R 1 SP>,R 2 SP>。 R 3 SP>。 R 4 SP>和R 5 SP>分别是独立的,也可以彼此相同或不同,并表示氢原子 1C-4C直链或支链烷基,氰基,硝基,羟基和甲氧基或乙氧基。 根据该制造方法,通过在活性炭的存在下使芳族硫醇化合物气相反应获得芳香族硫化物。 版权所有(C)2013,JPO&INPIT
摘要:
PROBLEM TO BE SOLVED: To solve the problem in which conventional compounds cannot sufficiently exert an inhibitory effect on DHODH (dihydroorotate dehydrogenase).SOLUTION: There are provided a compound such as 2-(cyclopropanecarbonyl-amino)-5-(2-phenylacetylamino-phenoxy)-benzoic acid, and a compound selected from salts thereof coupled with pharmaceutically allowable inorganic cations, which are used to provide the compound and pharmaceutical composition effective for clinical treatment of autoimmune disease, inflammatory disease, rejection to organ transplant and malignant neoplasm.